SCHEMBL19246799

SCHEMBL19246799

c1ccc(-c2nc(-n3c4ccccc4c4ccc5oc6ccccc6c5c43)nc3c2oc2ccccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.38
ALDH1A1 P00352 6/20 0.38
TSHR P16473 4/20 0.38
HPGD P15428 2/20 0.38
KDM4E B2RXH2 3/20 0.36
POLB P06746 2/20 0.36
LMNA P02545 5/20 0.36
HSD17B10 Q99714 2/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
CSF1R P07333 1/20 0.36
PDGFRB P09619 1/20 0.36
KIT P10721 1/20 0.36
FLT3 P36888 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
ADORA2A P29274 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
USP2 O75604 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22011576 0.90 MAPT (0.36) MAPTALDH1A1TSHRHPGDKDM4E
SCHEMBL19246725 0.89 MAPT (0.39) MAPTALDH1A1TSHRHPGDKDM4E
SCHEMBL18165441 0.88 MAPT (0.39) MAPTALDH1A1TSHRHPGDKDM4E
SCHEMBL19246798 0.88 KDM4E (0.36) MAPTALDH1A1TSHRHPGDKDM4E
SCHEMBL16905618 0.87 TSHR (0.44) MAPTALDH1A1TSHRHPGDKDM4E
SCHEMBL19046693 0.87 MAPT (0.38) MAPTALDH1A1TSHRHPGDKDM4E
SCHEMBL20408491 0.87 MAPT (0.39) MAPTALDH1A1TSHRHPGDKDM4E
SCHEMBL19679646 0.87 ALDH1A1 (0.35) MAPTALDH1A1TSHRHPGDKDM4E
SCHEMBL19997879 0.86 MAPT (0.38) MAPTALDH1A1TSHRHPGDKDM4E
SCHEMBL18962072 0.86 MAPT (0.35) MAPTALDH1A1TSHRHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10873034-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-12-22 US disclosed
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-08-17 US disclosed
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNA1, ARL1 MAPT 1277/4885ALDH1A1 139/4885TSHR 3601/4885
US-10873034-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CCNA1, ARL1 MAPT 1277/4885ALDH1A1 139/4885TSHR 3601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.